Research progress on antitumor effects of sea buckthorn, a traditional Chinese medicine homologous to food and medicine
Research progress on antitumor effects of sea buckthorn, a traditional Chinese medicine homologous to food and medicine
Xu et al., 2024 | Front Nutr | Systematic Review
Citation
Xu Duojie, Yuan Ling, ... Nan Yi. Research progress on antitumor effects of sea buckthorn, a traditional Chinese medicine homologous to food and medicine. Front Nutr. 2024;11:1430768. doi:10.3389/fnut.2024.1430768
Abstract
Sea buckthorn (Hippophae Fructus), as a homologous species of medicine and food, is widely used by Mongolians and Tibetans for its anti-tumor, antioxidant and liver-protecting properties. In this review, the excellent anti-tumor effect of sea buckthorn was first found through network pharmacology, and its active components such as isorhamnetin, quercetin, gallic acid and protocatechuic acid were found to have significant anti-tumor effects. The research progress and application prospect of sea buckthorn and its active components in anti-tumor types, mechanism of action, liver protection, anti-radiation and toxicology were reviewed, providing theoretical basis for the development of sea buckthorn products in the field of anti-tumor research and clinical application.
Key Findings
The research progress and application prospect of sea buckthorn and its active components in anti-tumor types, mechanism of action, liver protection, anti-radiation and toxicology were reviewed, providing theoretical basis for the development of sea buckthorn products in the field of anti-tumor research and clinical application.
Outcomes Measured
- Requires manual extraction
Population
| Field | Value |
|---|---|
| Population | See abstract |
| Sample Size | See abstract |
| Age Range | See abstract |
| Condition | See abstract |
MeSH Terms
- No MeSH terms indexed
Evidence Classification
- Level: Systematic Review
- Publication Types: Journal Article, Systematic Review
- Vertical: quercetin
Provenance
- PMID: 39045282
- DOI: 10.3389/fnut.2024.1430768
- PMCID: PMC11263281
- Verified: 2026-04-09 via PubMed E-utilities API
Source extracted via PubMed E-utilities API on 2026-04-09